GGrantIndex
Sort

78,016 grants matching breast cancer

How does malignancy subvert platelet and megakaryocytic biology?

$550,945
Elisabeth M Battinelli · Brigham And Women'S Hospital · R01 · FY2021 · CA

Congenic Mouse Medels of Melanoma for the Characterization of Tumor Immune Responses

$550,926
Marcus W Bosenberg · Yale University · R01 · FY2016 · CA

Validation and translation of a non-invasive, MR-guided breast cancer therapy

$550,885
Allison Payne · University Of Utah · R37 · FY2020 · CA

A BREAST CANCER PREVENTIVE ROLE FOR THE PEROXIDASE PEROXIREDOXIN 1

$550,882
The Medical University Of South Carolina · · FY2010 · Department of Defense

Cadherin11 in cancer & rheumatoid arthritis: Common target, common therapies? (5)

$550,881
Stephen W Byers · Georgetown University · R01 · FY2013 · CA

Emotion Regulation and Depression in Breast Cancer Survivorship

$550,878
Annette L Stanton · University Of California Los Angeles · R01 · FY2014 · CA

Eukaryotic Chromosome Replication

$550,865
Bonita J Brewer · University Of Washington · R01 · FY2013 · GM

Aging-related Traits and Disease Risk Factors in a Sardinian Population Cohort

$550,832
David Schlessinger · National Institute On Aging · ZIA · FY2013 · AG

Tumor selective inhibition of the WNT pathway

$550,824
Lukas Edward Dow · Weill Medical Coll Of Cornell Univ · R01 · FY2024 · CA

Characterizing Molecular Subtypes of Ovarian Cancer in African-American Women

$550,804
Jennifer A. Doherty · University Of Utah · R01 · FY2019 · CA

A Search for Small Molecule Inhibitors of the Hypoxia Response Pathway

$550,744
Kevin H Gardner · Ut Southwestern Medical Center · P01 · FY2011 · CA

Characterizing Molecular Subtypes of Ovarian Cancer in African-American Women

$550,732
Jennifer A. Doherty · University Of Utah · R01 · FY2021 · CA

Nitric Oxide as a Modifier of Oxidative Stress

$550,707
David Wink · Division Of Clinical Sciences - Nci · ZIA · FY2022 · CA

Racial and Socioeconomic Disparities in Breast Cancer Diagnostic Work Up and Outcomes

$550,682
Christoph I Lee · University Of Washington · R01 · FY2024 · CA

Image-guided combination therapy: noninvasive assessment of delivery and response

$550,634
Dmitri Artemov · Johns Hopkins University · R01 · FY2014 · CA

ACER2 in Chemotoxicity

$550,624
Cungui Mao · State University New York Stony Brook · P01 · FY2025 · CA

Biomarkers for predicting response to Hsp90 therapy

$550,587
Gabriela Chiosis · Sloan-Kettering Inst Can Research · R01 · FY2014 · CA

CHEMOTHERAPY DECISIONS AND OUTCOMES FOR THE ELDERLY

$550,574
Georgetown University · U10 · FY2005 · CA

Commercialization of Magnetic Nanobeads for Cancer Cell Enrichment

$550,572
Arfaan Rampersaud · Columbus Nanoworks, Inc. · R42 · FY2008 · CA

Multimodal MRI Biomarker of Mild Cognitive Impairment in Breast Cancer

$550,556
Jeffrey Scott Wefel · University Of Tx Md Anderson Can Ctr · R01 · FY2012 · NR

Chemotherapy & Cognition in Older breast Cancer Patients

$550,539
James P Grigsby · University Of Colorado Denver · R01 · FY2007 · AG

Bridging Geographic Barriers: Remote Cancer Genetics Counseling for Rural Women

$550,522
Anita Y Kinney · University Of Utah · R01 · FY2012 · CA

In Situ Albumin Binding siRNAs for Triple Negative Breast Cancer Tumor Penetration and Molecularly Targeted Therapy

$550,518
Craig Lewis Duvall · Vanderbilt University · R01 · FY2025 · CA

MCG Minority-Based Community Clinical Oncology Program

$550,477
Anand P Jillella · Augusta University · U10 · FY2009 · CA

MCG Minority-Based Community Clinical Oncology Program

$550,477
Anand P Jillella · Augusta University · U10 · FY2008 · CA